Industry News

newsicon-industry

News from the global pharmaceuticals industry about head lice treatments and corporate developments, including takeovers and mergers.

24.12.14 | Trading updates for head lice products

Two companies producing market-leading head lice products have released recent trading updates.

27.08.14 | TyraTech expands retailer base in UK

TyraTech has announced deals with further suppliers in the UK for their VaMousse head lice treatment.

24.07.14 | New Tyratech share & UK distribution deal

Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.

05.06.14 | VaMousse now available online across the US

TyraTech Inc recently announced that their VaMOUSSE! range of head lice products are available to purchase online in the United States.

24.01.14 | Tyratech to sell Vamousse through Walmart

Tyratech have recently announced a deal to sell Vamousse, their preventative head lice treatment product, through Walmart in the US.

07.10.13 | Tyratech discussing US distribution of head lice products

Tyratech Inc. is in discussions with distributors to increase the exposure of its head lice treatment range to markets in the US.

06.06.13 | Eden Research Licence Agreement

Eden Research has announced an agreement with Neo-Pharma Innovations to develop their terpene-based head lice treatment for commercial sale.

14.12.12 | New funding and efficacy data for Hatchtech

Hatchtech, Pty Ltd have announced the completion of their financing round and published new data on the active ingredient in their DeOvo pediculicide product.

13.12.12 | TyraTech receives Product Registration in UK

TyraTech, Inc, has received notification from the UK regualtory body that their VaMOUSSE!™ head lice product has been registered as a medical device.

13.09.12 | Successful End-Of-Phase-2 consultations for DeOvo

The anti-lice product DeOvo, developed by Hatchtech Pty Ltd, has successfully completed its end-of-phase II consultations with the FDA.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved